the lot thing. answer was that more said better A Yes. a than mine. All right, words, same but
use question. Here's human ever TRUVIEW you in quick the market? Can a
in plan and scope not or technology in intellectual to it the establish than want and or have the whether around we do as some we easy AI many TRUVIEW that, likely and to would for the property opportunity. be The the consider an get one the monetize market again, way, more manufacturers whether the outright. one. for built data would would is, it nearly so but we some licensing that veterinarian we to that on, out human Yes. it device, also be -- application foothold and ourselves, to we opportunity our licensing establish to likely, it a TRUVIEW as And would, answer is own And a TRUVIEW
reasons which conference both while have reverse understand on there question this we to We that shareholders split. that's Let's in decision. plans of just common, which from people. what is we've see. reverse on requires before of effect call There's this, do that are another that's to kind I'll remind if each approval plans very just we and do it. question a vote sides, repeat a have And sort split, we me it, have no at point, that said And to would no plans for is that everyone a let that our two-thirds even important
won't conjunction think it, idea. so, our ever on And And our won't that it good that I two-thirds with deciding to would us was in it don't we just -- decide of it if be be would it shareholders own now. a us do it, saying do happen
So, plan in again, our now. not right
expect much a Someone revenue. expect to we where have question would else higher that, say would we that as five I in years. a company, And just about I asked be
We continue really solid to maintain margins.
of we to continue Beyond it, either additional that technology of I with is features. our or say And would the product edge our line health. intend all that animal refresh on that, in to cutting extensions technology, of technology,
and on example, as soon ready. the working device, AI TRUVIEW component roll to it's For that as rapidly an launched it. We're the we've out now we'll developing
we'll to cutting to think relevant at We continue be veterinarians. of to the we so always edge be expect technology,
flow, improve of for but it, for of come parents, increasing only we them and the is booth, veterinarians care -- over when trade that a show, is for helping have they they'll time the their for our pet Frankly, and workflow them profitability. the also major satisfaction not cash quality our something us, is and pets see because beeline every the hit a make goal
into existing I it. and an rep some what got ordered was products and left they sales was the had and thrilled and wanted went before they're had all And in know we account field and and they the what of with to it yesterday, TRUVIEW, new, our installed recently there, just with next. visited veterinarians they the
want veterinarian we experience. So, every same that have to
being How Are added the a one. basis? Here's are shows regular going? on customers new
Yes.
infrastructure think able because be shows, the necessary these to the invested veterinarians we in that to part it's purchasing of do trade an I important do.
expense added on shouldered forth. an booth, seamlessly into sort only PulseVet, And It events products our and and in and the and TRUFORMA all so show by was TRUFORMA now other trade at then of so are so was there first. our speaking and of
in And so, marketing side. some get on there there leverage to considerable we're leverage starting -- the
revenue therapeutic comes A from question of diagnostic here. expect generate Most When products. to revenue growth? products the do quarterly significant you
taking they're has of But certainly -- the base. growth generating off the revenue nicely. significant a terms a been to as off percentage Well, growth of in are all it's they date growth, small
instrument So the in used. place to the no that and to are then industry at animal for standard charge health, and diagnostics consumables it's charge, remember
And a then, with is what we do. the the so with little doing, differently what with that is TRUVIEW. TRUFORMA, our bit that TRUVIEW, but also we're And
at the the itself. we of practices. the the the that like yet the one established of to other we've just accuracy tests of as clinic. TRUFORMA that technology, point We instruments test. very of any revenue will do in into device -- difficult of None vet TRUFORMA nice And say uptake that tests do being -- TRUFORMA, care. some that really the established for with would the with it you in at say with also can't terms are And do But in solid, all market--leading speaks technology TRUFORMA, I that we growth incredible that TRUFORMA brought in had I the really
are available some care, by they're big fourth point GI, quarter, run of of which products is now not a assays, most should but say, with with vet assay needs not an these, emergent which top the the run the veterinarians. vet on Cobalamin, deal, tests or has commonly reasons basis. bring our cat next non-infectious diarrhea three of the Folate, we is Because assays a the their bring to it also or only three vet the launch expect to people or And your Having that's these and pet dog why these in assays, established you cPL, are vomiting. what at that the to I because one to when
So, quickly the will our installed we expect growth One, our a bring installed all to And things. the accelerate That's of expect base we side. on assays of couple in. those of existing our that we base. companion expect actually that animal --
as to first the When sit a thing, do the it's called currently part launching, experience with Cushing's disease, That's super PPID. a for they you of diagnosed, very XX first have get today, equine Horses is it clinic, medicine. we'll with for very straightforwardly excited, and be diagnosis for or good which they're in with Cushing's equine horses. it and to which them disease a is side, the And XX-years-old, susceptible, could get be easily or over we're in assay, disease currently right? here we not having -- susceptible we're are If highly quickly is clinic the Cushing's. because assay horse process. our it. it treated are next the This we of that
could the it's the horse On survive, many even down. they be never hard a But they very put then they same. They'll it's horse. cases hand, it, develop other which And if in to laminitis, the rough get diagnose. means experience the if for miss
endogenous Well, the Cushing's screen for disease ACTH. is equine
you get have get as comes as Now today, country, one frozen, wanted it's to and and out lab, going to it you're before it to it's to a you the send -- so or and Whether of keep and it screen have facility this you sample, send or a back, they in endogenous it you'd the directly to freeze it not it capture you send if or really it IDEXX do Cornell, widely to then to horse, to Cornell that's Cornell. soon would week it the ACTH, for used. only send a
something eACTH On We'll horses equipment stall the that do provide is other our can the no site. for charge. hand, they at
We charge to a can't a once imagine you year equine vet price horse saying imagine reasonable a for price be customers, I money not to a the price with their make from a it, for them to owner. nice They'll of them assay. charge think the I that double offering of an horse about owner will and horse And all capital fair no Cushing's. fair because when no keep to help assay a they'll getting outlay. a amount to their it can't able
in up device -- provide pick therapy so, equine shockwave about the a there are those we up to vets market and usage, country. a XXX And when PulseVet horse. about currently of And size, think vets, times pick X,XXX because about X,XXX equine the a year, average that's the
in they of such are they horses years of well, thirteen there's X older So million age the over Zomedica, States. pool of, a age the United know and There large PulseVet, know horses. are
that opportunity us huge business. to So for grow
them have first charge standard slides fee sort XXX industry And a charge device. the their to automatically Now for fee per charge of be thereafter, then for monthly we that report. that'll they covers we pathology instrument, a certain then processed amount that the report, get with we the each TRUVIEW, a time slide. by And pathology
And we see is until won't so and example, and when those. won't in revenue in So, that we on what see that July, the we put July revenue devices for for and we in because those all we -- August forth. ones bill arrears, some put out June, so means then for and
bit able dominance probably of to question. the interesting installed didn't to we're the or our little of VetGuardian, going base. that that's on diagnostics. PulseVet as And look the a to see take its whether be enough whether future, -- into to that's I surpass not that with continues think historical or but to revenue I So even build it's as build get for revenue it's going we But we time to that
Vets I'm any not you haven't Canada incorporated. spoke to sales Canada? Zomedica in seeing of Have Alberta in in done where heard we're here. even I
And who have slides we in have this and lot. them don't he's Canada, Canada, PulseVet technicians met But on consolidating they So, I of there. their do we have salesperson will because, have not or so they conference, at of a I Assisi one equine on We you or on that, tell the one them PulseVet in at were really with of showing that And their but of a horses. have thing a and same conference, distributor. and a were also representative in that I sales using XX there. in gentleman practices, TRUFORMA XX planning We don't U.S. national don't the Canada, a doing they showing was impressed is
so have And told I the his acquaintance. gathering. Cushing's experience I are acquaintance. made up, the talked CEO. early And the -- participating clinical him made coming and about He's disease equine we we a screen, they that in bit, I his that little now and
of business that forward. see we'll expect more an in move Canada increase in I we So, as
to the One have help acquire is, product? financing vets you do question here options available
haven't We to. absolutely. answer but could, is, the had directly finance that need yes, we ourselves. And We don't to a
very finance generator $XX,XXX, for outlay required. us capital PulseVet, arms linked need we a which to no TRUFORMA, to we $X,XXX, for it's we With no a Assisi, With amount sell reasonable a with company. TRUVIEW, which a even certain have third-party sell and With it. month, it's amount. with do VetGuardian, So, finance the there's
vet. a it's good really and -- for So the deal
it's the the money six for $XX, a is payments next months, literally $XXX There's no PulseVet, $XXX a there So, for then month, month. but months. And for down. no six
$XXX. year, first they're So out the
with trodes going times through market two on up they're the They're small XXX average the experience them. that our a Now picking been has handpieces, have that animal treatments year. each PulseVet two in or XX
as they treatments done. many they've So, we those know buy trodes, how
And procedures that could pop, that $XX,XXX. in so, that that's a year at we're $XXX do seeing XXX they first
have prepayment out, early stock they've lock, year, they've So an really to while whole for pay program the cash doesn't enough thing, barrel, generated paid only within and that and cash almost a $XXX penalty. financing in
they're year. but the subscription is in typically only machine. buying VetGuardian, with Same there It's an thing annual second beginning $X,XXX,
over the they're three subscription years years. in three bundling financing So, machine and of it
And been nicely. really so working out that's
so Why taking assays see. out? long Let's come are to the
that's myself, the our I up all asked tell this That's ability that here. year we not had the the until And those assays you and our I, I reason got we I -- really manufacture Qorvo a why, Qorvo we now where that pace. now, ability also the won't while own to develop with, the deal the Biotech, to when first that instruments. have assays own question include reasons at belabor assays will renegotiated And our to manufacture in develop January, our cartridges to to have until own
We've this in year, began into process, continuing they're will and people hired will ordered up process. I We've the At on in announced, later Georgia time, R&D. this they're we R&D next doing. year. the Now installed which do January, during the training process. next we training as wave the to that The They're working They're on people manufacture. to on our equipment of assays a people announced previously the assays. same we've through go finishing which be the begun the equipment. our They're manufacturing
higher that this year. means OpEx our that is All
this because ourselves, people then we're lower are to a basically our things, margins Our them train them of higher to do mean transition paying where people. All the of and year, and into for to that, hiring assay were cost spend developing next before. this early year, we an we'll what get because XX% but year well it, a beyond worth third very we once developing paying
human also share our on vet assays completely the market. for of More unlike, be the business focus health which importantly, of kind our getting focus, a had the and lion's was partner will company,
we took market not much long, And we and why so so human market. but quarter for can what be going rather an so the we'll assay the equine expect this quarter for -- forward, next launching
worried know market Let's Is is flat rate? see here. company manipulation We short real stock thing. the are a keeping at all that the a sellers
you. for one's that Peter,
